MeVis Medical Solutions AG

LSE:0HI7 Stock Report

Market Cap: €45.9m

MeVis Medical Solutions Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Marcus Kirchhoff

Chief executive officer

€327.0k

Total compensation

CEO salary percentagen/a
CEO tenure12.8yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure4.3yrs

Recent management updates

No updates

Recent updates

CEO Compensation Analysis

How has Marcus Kirchhoff's remuneration changed compared to MeVis Medical Solutions's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

€6m

Dec 31 2023n/an/a

€5m

Sep 30 2023€327kn/a

€5m

Jun 30 2023n/an/a

€6m

Mar 31 2023n/an/a

€6m

Dec 31 2022n/an/a

€7m

Sep 30 2022€316kn/a

€8m

Jun 30 2022n/an/a

€7m

Mar 31 2022n/an/a

€6m

Dec 31 2021n/an/a

€5m

Sep 30 2021€307k€298k

€5m

Jun 30 2021n/an/a

€5m

Mar 31 2021n/an/a

€5m

Dec 31 2020n/an/a

€5m

Sep 30 2020€303k€294k

€6m

Jun 30 2020n/an/a

€7m

Mar 31 2020n/an/a

€7m

Dec 31 2019n/an/a

€7m

Sep 30 2019€279k€270k

€8m

Jun 30 2019n/an/a

€8m

Mar 31 2019n/an/a

€9m

Dec 31 2018n/an/a

€8m

Sep 30 2018€249k€240k

€8m

Compensation vs Market: Marcus's total compensation ($USD337.57K) is about average for companies of similar size in the UK market ($USD352.54K).

Compensation vs Earnings: Marcus's compensation has been consistent with company performance over the past year.


CEO

Marcus Kirchhoff (55 yo)

12.8yrs

Tenure

€327,000

Compensation

Mr. Marcus Kirchhoff has been the Chief Executive Officer, Chairman of the Board and Member of the Executive Board at MeVis Medical Solutions AG since March 1, 2012. Mr. Kirchhoff serves as Vice President...


Board Members

NamePositionTenureCompensationOwnership
Shubham Maheshwari
Deputy Chairman of Supervisory Board3.8yrsno datano data
Sunny Sanyal
Member of Supervisory Board4.3yrsno datano data
Kimberley Honeysett
Chairperson of Supervisory Board7.8yrsno datano data

4.3yrs

Average Tenure

54yo

Average Age

Experienced Board: 0HI7's board of directors are considered experienced (4.3 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 12:21
End of Day Share Price 2024/11/20 00:00
Earnings2024/03/31
Annual Earnings2023/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

MeVis Medical Solutions AG is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael BissingerDz Bank Ag
FELIX ELLMANNWarburg Research GmbH
Harald HofWarburg Research GmbH